Atai Beckley Inc. (ATAI)
$7.35+0.00%Close
BUYBULL · day 36
Key stats
- Market cap
- $2.7B
- Beta
- 1.55
- Div yield
- 91.84%
- P/E (TTM)
- -2.53
- 1W
- +0.14%
- 1M
- +1.66%
- vs SPY 1W
- -1.02%
- vs SPY 1M
- -1.33%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHSELLDianthus Therapeutics, Inc.$4.6BCRISISQ 2$82.37-0.07%
- RLAYSELLRelay Therapeutics, Inc.$3.9BRECOVERYQ 3$17.88+2.70%
- AMLXSELLAmylyx Pharmaceuticals, Inc.$3.1BCRISISQ 8$28.14+3.46%
- ELVNSELLEnliven Therapeutics, Inc.$2.9BCRISISQ 11$40.98+0.86%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.5BCRISISQ 17$16.99+0.53%
- INBXSELLInhibrx Biosciences Inc.$1.4BCRISISQ 33$95.01+2.43%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.99-0.33%
- NKTRSELLNektar Therapeutics$1.2BCRISISQ 12$41.17+0.91%
- IMTXSELLImmatics N.V.$996MCRISISQ 6$7.43+0.81%
- SANASELLSana Biotechnology, Inc.$776MCRISISQ -5$2.79+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATAI?
- LOPJLB’s latest quantitative signal on Atai Beckley Inc. (ATAI) is BUY in a BULL regime. Signals are updated daily.
- What market regime is ATAI in?
- Atai Beckley Inc. (ATAI) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Atai Beckley Inc. (ATAI) do?
- Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada. Its development pipeline features several key compounds: BPL-003: An intranasally administered formulation…